Berylson Capital Partners, LLC Orchard Therapeutics PLC Transaction History

Berylson Capital Partners, LLC

  • $39.6 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$5.65 - $15.71 $1.17 Million - $3.26 Million
-207,200 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$10.15 - $15.58 $871,387 - $1.34 Million
85,851 Added 70.75%
207,200 $2.85 Million
Q1 2019

May 15, 2019
BUY
$12.01 - $19.49 $1.46 Million - $2.37 Million
121,349 New
121,349 $2.17 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Berylson Capital Partners, LLC Portfolio

Follow Berylson Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berylson Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berylson Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email